刘小华,张忠林,李文瑜,梁长虹,刘再毅,易晓敏.DWI中基于单指数与IVIM双指数模型早期预测淋巴瘤疗效效能比较[J].中国医学影像技术,2014,30(11):1636~1640
DWI中基于单指数与IVIM双指数模型早期预测淋巴瘤疗效效能比较
Monoexponential and biexponential model based on intravoxel incoherent motion in DWI for early predicting chemotherapy response in patients with lymphoma: A comparision analysis
投稿时间:2014-05-12  修订日期:2014-09-01
DOI:
中文关键词:  体素内不相干运动  扩散磁共振成像  淋巴瘤
英文关键词:Intravoxel incoherent motion  Diffusion magnetic resonance imaging  Lymphoma
基金项目:
作者单位E-mail
刘小华 广东省医学科学院 广东省人民医院放射科, 广东 广州 510080  
张忠林 广东省医学科学院 广东省人民医院放射科, 广东 广州 510080 gzzhangzl@sina.cn 
李文瑜 广东省医学科学院 广东省人民医院肿瘤科, 广东 广州 510080  
梁长虹 广东省医学科学院 广东省人民医院放射科, 广东 广州 510080  
刘再毅 广东省医学科学院 广东省人民医院放射科, 广东 广州 510080  
易晓敏 广东省医学科学院 广东省人民医院放射科, 广东 广州 510080  
摘要点击次数: 3379
全文下载次数: 1147
中文摘要:
      目的 比较多b值DWI中单指数模型和基于体素内不相干运动(IVIM)的双指数模型早期预测淋巴瘤疗效的价值。方法 纳入接受化疗、经病理确诊的淋巴瘤患者22例。患者于治疗前、2个周期化疗后分别进行常规MRI和多b值DWI, 根据IVIM双指数模型获得真性扩散系数(D值)、假性扩散系数(D*值)和灌注分数(f值), 根据单指数模型获得ADC值。2个周期化疗后根据实体瘤疗效评价标准评估疗效, 分为完全缓解(CR)、部分缓解(PR)、稳定(SD)和进展(PD), 比较不同疗效组治疗前D、f、D*、ADC值差异, 评价D值和ADC值预测疗效效能。结果 CR组49个淋巴结、PR组17个淋巴结、SD组8个淋巴结。CR组和PR组治疗前D值和ADC值差异均无统计学意义(P均 >0.05), SD组治疗前D值和ADC值均低于CR组和PR组(P均 <0.05), CR组、PR组和SD组f值和D*值差异均无统计学意义(P均 >0.05)。分别以0.48×10-3mm2/s和0.49×10-3mm2/s为治疗前D值和ADC值预测较好疗效(CR和PR)阈值, 敏感度、特异度和曲线下面积分别为100%、75.76%、0.890和100%、84.85%、0.893, 二者预测化疗疗效差异无统计学意义(Z=0.086, P=0.931)。结论 基于IVIM的双指数模型所获得D值和单指数模型所获得ADC值早期预测淋巴瘤疗效效能均较好, 无明显差异。
英文摘要:
      Objective To compare the prediction efficacy for chemotherapy response of lymphoma between monoexponential and biexponential model based on intravoxel incoherent motion (IVIM) in multiple b value DWI. Methods Totally 22 patients of lymphoma confirmed by pathology who received chemotherapy underwent regular MRI and multiple b value DWI before and after 2 cycles of chemotherapy. The true diffusion coneffcient (D), pseudo diffusion coneffcient (D*) and perfusion fraction (f) were obtained according to the biexponential model, and the apparent diffusion coefficient (ADC) was obtained according to the monoexponential model. The chemotherapy response of lymphoma were classified into complete response (CR), partial response (PR), stable disease (SD) and progressive disease (PD) according to response evaluation criteria in solid tumors after 2 cycles of chemotherapy. Pretherapeutic D, f, D* and ADC value among different response groups were compared. The prediction efficacy of D and ADC value for chemotherapy response were assessed. Results There were 49 lymphoma nodes in CR group, 17 lymphoma nodes in PR group and 8 lymphoma nodes in SD group. Pretherapeutic D and ADC value in SD group were lower than those in CR and PR group (all P <0.05), which had no differences between CR and PR group (both P >0.05). There were no difference of f and D* value among CR, PR, and SD group (all P >0.05). Taken 0.48×10-3 mm2/s and 0.49×10-3 mm2/s as cut-off value of pretherapeutic D and ADC value for predicting good chemotherapy response (CR and PR), the sensitivity, specificity and area under the curve was 100%, 75.76%, 0.890 and 100%, 84.85%, 0.893, respectively, with no statistical difference of prediction efficacy between D and ADC (Z=0.086, P=0.931). Conclusion D value obtained from biexponential model based on IVIM and ADC value obtained from monoexponential model can both early predict the chemotherapy response of lymphoma, with similar prediction efficacy.
查看全文  查看/发表评论  下载PDF阅读器